Literature DB >> 9422249

The Chiari malformations: a constellation of anomalies.

R M Shuman1.   

Abstract

The Chiari malformations form a group of abnormalities that are pathogenetically interrelated. The most important member of the group is the Chiari type II malformation, known as the Arnold-Chiari malformation. Its cardinal features are the myelomeningocele in the thoraco-lumbar spine, the venting of the intracranial cerebrospinal fluid through the central canal, the hypoplasia of the posterior fossa, the herniation of hindbrain into the cervical spinal canal, and the compressive damage to cranial nerves. Some of the abnormalities are progressive, and thus treatable. Limitation of progression may improve outcomes. The challenges to our treatment programs involve early diagnosis, delivery by Caesarean section, emergent closure of the neural plaque and prophylaxis of hydrocephalus, anticipatory prevention of the neurological compression syndromes, multidisciplinary teams, and age-appropriate interventions.

Entities:  

Mesh:

Year:  1995        PMID: 9422249     DOI: 10.1016/s1071-9091(05)80033-6

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  3 in total

1.  Identification of the large descending tracts using diffusion tensor imaging in Chiari III malformation.

Authors:  Amir Zolal; Petr Vachata; Ales Hejcl; Alberto Malucelli; Robert Bartos; Martin Sames
Journal:  Childs Nerv Syst       Date:  2010-04-23       Impact factor: 1.475

2.  The old and the new: supratentorial MR findings in Chiari II malformation.

Authors:  Elka Miller; Elysa Widjaja; Susan Blaser; Maureen Dennis; Charles Raybaud
Journal:  Childs Nerv Syst       Date:  2007-11-20       Impact factor: 1.475

3.  Cerebral Abnormalities in Spina Bifida: A Neuropathological Study.

Authors:  Fabienne Paschereit; Kim Hannah Schindelmann; Michael Hummel; Joanna Schneider; Gisela Stoltenburg-Didinger; Angela M Kaindl
Journal:  Pediatr Dev Pathol       Date:  2021-10-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.